Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
124,152,367
-
Shares change
-
-147,358
-
Total reported value, excl. options
-
$3,436,416,158
-
Value change
-
+$2,487,658
-
Put/Call ratio
-
16.68%
-
Number of buys
-
108
-
Number of sells
-
-71
-
Price
-
$27.68
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2019
225 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q4 2019.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124,152,367 shares
of 334,352,960 outstanding shares and own 37.13% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10,853,129 shares), BlackRock Inc. (9,594,660 shares), PERCEPTIVE ADVISORS LLC (9,416,202 shares), Avoro Capital Advisors LLC (8,826,039 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,509,856 shares), FARALLON CAPITAL MANAGEMENT LLC (6,250,000 shares), ORBIMED ADVISORS LLC (5,548,326 shares), FRANKLIN RESOURCES INC (5,477,756 shares), GREAT POINT PARTNERS LLC (5,015,175 shares), and STATE STREET CORP (4,324,176 shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.